carbamates has been researched along with Anticholinergic Syndrome in 1 studies
Anticholinergic Syndrome: Adverse drug effects associated with CHOLINERGIC ANTAGONISTS. Clinical features include TACHYCARDIA; HYPERTHERMIA; MYDRIASIS, dry skin and dry mucous membranes, decreased bowel sounds and urinary retention in peripheral anticholinergic syndrome; and HALLUCINATIONS; PSYCHOSES; SEIZURES; and COMA in central anticholinergic syndrome.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Indira, M | 1 |
| Andrews, MA | 1 |
| Rakesh, TP | 1 |
1 other study available for carbamates and Anticholinergic Syndrome
| Article | Year |
|---|---|
Incidence, predictors, and outcome of intermediate syndrome in cholinergic insecticide poisoning: a prospective observational cohort study.
Topics: Adult; Aged; Anticholinergic Syndrome; Carbamates; Cholinergic Antagonists; Cohort Studies; Female; | 2013 |